Internet Pioneer In...
Health Care: Drugs
Cadence Pharmaceuticals Inc. (CADX: NASDAQ)
$2.74 0.04 | 1.29%
06/04/12 - 03:44 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 82.61M | 112.18M | 75.86M | 47.63M |
| Receivables | 2.70M | 0.00 | 0.00 | 0.00 |
| Inventories | 1.39M | 485.00K | 0.00 | 0.00 |
| Other Current Assets | 90.00K | 36.00K | 31.26K | 75.56K |
| Total Current Assets | 132.93M | 136.04M | 84.05M | 50.04M |
| Property, Plant & Equipment, Gross | 14.59M | 11.40M | 9.98M | 5.64M |
| Accumulated Depreciation & Depletion | 4.02M | 2.41M | 1.68M | 1.16M |
| Property, Plant & Equipment, Net | 10.57M | 8.99M | 8.30M | 4.48M |
| Intangibles | 13.43M | 15.00M | 0.00 | 0.00 |
| Other Non-Current Assets | 7.23M | 3.76M | 209.45K | 628.38K |
| Total Non-Current Assets | 31.23M | 27.74M | 8.51M | 5.11M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 164.16M | 163.79M | 92.56M | 55.15M |
| Accounts Payable | 3.80M | 3.42M | 2.66M | 4.88M |
| Short Term Debt | 0.00 | 4.02M | 6.44M | 7.69M |
| Other Current Liabilities | 0.00 | 0.00 | 22.05K | 22.05K |
| Total Current Liabilities | 16.04M | 14.72M | 16.86M | 21.66M |
| Long Term Debt | 28.70M | 24.65M | 0.00 | 6.10M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 117.00K | 447.00K | 640.21K | 952.27K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 28.81M | 25.10M | 640.21K | 7.05M |
| Total Liabilities | 44.85M | 39.83M | 17.50M | 28.71M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 119.31M | 123.96M | 75.06M | 26.44M |
| Common Par | 9.00K | 6.00K | 5.05K | 3.84K |
| Additional Paid In Capital | 485.98M | 397.62M | 292.08M | 197.96M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -366.68M | -273.66M | -217.02M | -171.53M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 2.00K | 0.00 | 60.00 | 0.00 |
| Total Capitalization | 148.01M | 148.61M | 75.06M | 32.54M |
| Total Equity | 119.31M | 123.96M | 75.06M | 26.44M |
| Total Liabilities & Stock Equity | 164.16M | 163.79M | 92.56M | 55.15M |
| Total Common Shares Outstanding | 85.51M | 63.11M | 50.48M | 38.36M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 66.08M | 52.04M | 48.75M | 36.82M |
| Diluted Weighted Shares Outstanding | 66.08M | 52.04M | 48.75M | 36.82M |
| Number of Employees | 220 | 247 | 90 | 55 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with CADX
- Portfolio NameUser Type
- Contributor8 Stocks Below $10 To Avoid
- Contributor10 Most Shorted Stocks in B...
- ContributorRelative Strength Stocks 09...
- Usergrainey Portfolio 1
- Useryourguess Portfolio 1
- Userlives288
- UserCarl Nicola Portfolio 1
- Userron stewart
Latest CADX Headlines from TheStreet
- 8 Stocks Under $10 to Avoid at All Costs 12.23.11 | 12:12 pm
- Pacira: Exparel Approval Easy, Selling Painkiller Harder Challenge 10.31.11 | 11:10 am
- 5 Stocks Showing Relative Strength in a Weak Market 09.22.11 | 02:09 pm
- Biotech Stock Mailbag: Cadence Pharma 03.11.11 | 07:03 am
- Biotech Sector Weekly Rewind 11.06.10 | 09:11 am
- Cadence CEO Discusses Q3 2010 Results - Earnings Call Transcript 11.05.10 | 02:11 pm
- Cadence: When A Drug Approval Sinks Stock 11.03.10 | 10:11 am
- FDA Ends October With Drug Approvals, Rejection 11.01.10 | 07:11 am
- Biotech Stock Mailbag: Exact Sciences 10.15.10 | 07:10 am
- 21 Drugs Facing FDA Approval Decisions 08.31.10 | 08:08 am
Press Releases for CADX
- Cadence Pharmaceuticals Announces Proposed Public Offering Of Common Stock - PR Newswire 11.08.10 | 06:11 am
Partner Headlines for CADX
- Cadence: Not Altering Sales Projections Or Rating In Aftermath Of Product Recall - Seeking Alpha 02.08.12 | 09:02 am
- Cadence Pharmaceuticals: Good For Patients, Bad For Investors - Seeking Alpha 12.26.11 | 08:12 am
- Wedbush Lowers Cadence PT to $10 from $15 - Benzinga 11.23.11 | 01:11 pm
- Company News for November 18, 2011 - Corporate Summary - Zacks 11.18.11 | 10:11 am
- Options Brief: Cadence Pharmaceuticals - Benzinga 07.15.11 | 01:07 pm
- Cadence: Not Unduly Concerned About ANDA Filing Against Ofirmev - Seeking Alpha 07.05.11 | 09:07 am
- 6 Speculative Biotech Stocks Smart Money Loves - Seeking Alpha 05.23.11 | 09:05 am
- Top 15 Most Undervalued Biotech Stocks By Analyst Target Price - Seeking Alpha 04.08.11 | 03:04 pm
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- Cadence Pharmaceuticals: A Rising Star - Seeking Alpha 03.13.11 | 09:03 am
